Why Generic Pills Change Color and Shape: A Patient Safety Guide
Explore why generic pill appearances change, how regulations shape them, and what patients can do to manage safety confidently.
Read MoreTag: generic drugs
Medication Therapy Management: How Pharmacists Optimize Generic Drugs for Better Outcomes
Medication Therapy Management helps pharmacists optimize drug regimens, especially by switching patients to affordable generic alternatives. This service improves adherence, cuts costs, and prevents dangerous interactions-all while empowering patients with clear, evidence-based guidance.
Read More
WHO Model Formulary: International Standards for Essential Generics
The WHO Model List of Essential Medicines sets global standards for affordable, life-saving generics. Used by over 150 countries, it drives access to critical treatments by prioritizing safety, effectiveness, and cost - not profit.
Read More
Bioequivalent medications: what the term really means and why it matters
Bioequivalent medications are generic drugs proven to work the same as brand-name versions in your body. Learn how regulators test them, when they might not be interchangeable, and why they save billions without risking your health.
Read More
Generics vs Brand-Name Drugs: What Insurance Actually Covers and Why It Matters
Insurance plans treat generic and brand-name drugs very differently - with lower copays for generics, mandatory substitutions, and strict rules for brand access. Understand how formularies, step therapy, and prior authorization affect your costs and care.
Read More
Elderly Patients Switching to Generics: What You Need to Know About Safety and Effectiveness
Elderly patients switching to generics can save money, but age-related changes in metabolism, kidney function, and polypharmacy increase risks. Learn which drugs need caution, how to spot problems, and what to ask your doctor.
Read More
Hatch-Waxman Act: How It Built the U.S. Generic Drug System
The Hatch-Waxman Act created the modern system for generic drugs in the U.S., balancing patent protection for innovators with faster access to affordable medicines. It saved billions but now faces abuse from patent thickets and pay-for-delay deals.
Read More